Gilead Sciences
GILD
GILD
1,557 hedge funds and large institutions have $140B invested in Gilead Sciences in 2015 Q2 according to their latest regulatory filings, with 152 funds opening new positions, 640 increasing their positions, 604 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,557
Holders Change
+67
Holders Change %
+4.5%
% of All Funds
41.99%
Holding in Top 10
275
Holding in Top 10 Change
+95
Holding in Top 10 Change %
+52.78%
% of All Funds
7.42%
New
152
Increased
640
Reduced
604
Closed
71
Calls
$2.23B
Puts
$3.7B
Net Calls
-$1.47B
Net Calls Change
-$231M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
+$830M |
| 2 |
D.E. Shaw & Co
New York
|
+$439M |
| 3 |
ECU
Egerton Capital (UK)
London,
United Kingdom
|
+$376M |
| 4 |
EIP
Epoch Investment Partners
New York
|
+$330M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$290M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$1.14B |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$646M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$420M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$414M |
| 5 |
State Street
Boston,
Massachusetts
|
-$370M |
